[go: up one dir, main page]

PL365874A1 - Dyspersje do wytwarzania słabo lub trudno rozpuszczalnych składników aktywnych - Google Patents

Dyspersje do wytwarzania słabo lub trudno rozpuszczalnych składników aktywnych

Info

Publication number
PL365874A1
PL365874A1 PL01365874A PL36587401A PL365874A1 PL 365874 A1 PL365874 A1 PL 365874A1 PL 01365874 A PL01365874 A PL 01365874A PL 36587401 A PL36587401 A PL 36587401A PL 365874 A1 PL365874 A1 PL 365874A1
Authority
PL
Poland
Prior art keywords
dispersions
active ingredients
emulsion
sparingly soluble
soluble active
Prior art date
Application number
PL01365874A
Other languages
English (en)
Inventor
Rainer Helmut Müller
Original Assignee
Pharmasol Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7650573&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL365874(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmasol Gmbh filed Critical Pharmasol Gmbh
Publication of PL365874A1 publication Critical patent/PL365874A1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PL01365874A 2000-07-28 2001-07-27 Dyspersje do wytwarzania słabo lub trudno rozpuszczalnych składników aktywnych PL365874A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10036871A DE10036871A1 (de) 2000-07-28 2000-07-28 Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
PCT/EP2001/008726 WO2002009667A2 (de) 2000-07-28 2001-07-27 Dispersionen zur formulierung wenig oder schwer löslicher wirkstoffe

Publications (1)

Publication Number Publication Date
PL365874A1 true PL365874A1 (pl) 2005-01-10

Family

ID=7650573

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01365874A PL365874A1 (pl) 2000-07-28 2001-07-27 Dyspersje do wytwarzania słabo lub trudno rozpuszczalnych składników aktywnych

Country Status (15)

Country Link
US (2) US7060285B2 (pl)
EP (1) EP1305006B1 (pl)
JP (1) JP2004505032A (pl)
KR (1) KR20020063869A (pl)
CN (1) CN1620283A (pl)
AT (1) ATE401055T1 (pl)
AU (1) AU8976801A (pl)
BR (1) BR0107042A (pl)
CA (1) CA2388550A1 (pl)
DE (2) DE10036871A1 (pl)
ES (1) ES2307644T3 (pl)
MX (1) MXPA02003114A (pl)
PL (1) PL365874A1 (pl)
RU (1) RU2002111336A (pl)
WO (1) WO2002009667A2 (pl)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188843B (pl) * 2000-06-22 2002-11-09 Vinod Daftary Gautam Dr
DE10036871A1 (de) * 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
EP1279402B1 (en) * 2001-07-26 2006-11-29 Ethypharm Coated granules of allylamine-or benzylamine-anti-mycotics, process for preparation thereof and orodispersible tablets containing said coated granules
ATE468107T1 (de) * 2001-11-01 2010-06-15 Yissum Res Dev Co Verfahren und zusammensetzung zur behandlung von trockenen augen
US6656460B2 (en) 2001-11-01 2003-12-02 Yissum Research Development Method and composition for dry eye treatment
US20040022820A1 (en) * 2001-11-28 2004-02-05 David Anderson Reversed liquid crystalline phases with non-paraffin hydrophobes
CN100391464C (zh) * 2001-12-03 2008-06-04 诺瓦西股份有限公司 含活性维生素d化合物的药物组合物
AU2003277299B2 (en) * 2002-04-10 2009-12-10 Conforma Therapeutics Corporation Drug formulations having long and medium chain triglycerides
KR100533458B1 (ko) * 2002-07-20 2005-12-07 대화제약 주식회사 파클리탁셀의 가용화용 조성물 및 그의 제조 방법
KR100587177B1 (ko) * 2002-09-12 2006-06-08 한불화장품주식회사 히아루론산나트륨을 유화안정화제로 이용한 화장료 조성물
US20050026877A1 (en) * 2002-12-03 2005-02-03 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
CA2517310C (en) 2003-02-28 2015-11-24 Chugai Seiyaku Kabushiki Kaisha Stabilized protein-containing formulations comprising a poloxamer
US20050020546A1 (en) * 2003-06-11 2005-01-27 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
PE20050596A1 (es) * 2003-12-19 2005-10-18 Novartis Ag Microemulsion que comprende un inhibidor renina
WO2006003519A2 (en) * 2004-07-02 2006-01-12 Novagali Pharma Sa Use of emulsions for intra: and periocular injection
DE602004022523D1 (de) * 2004-07-02 2009-09-24 Novagali Pharma Sa Verwendung von Emulsionen zur intra- und periocularen Injection
US9993558B2 (en) * 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
GB0501835D0 (en) * 2005-01-28 2005-03-09 Unilever Plc Improvements relating to spray dried compositions
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US8288348B2 (en) * 2005-07-13 2012-10-16 Allergan, Inc. Cyclosporin compositions
RU2433818C2 (ru) 2005-08-31 2011-11-20 АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи Композиции, включающие слаборастворимые в воде фармацевтические вещества и противомикробные вещества
EP1928435B8 (en) * 2005-08-31 2019-03-20 Abraxis BioScience, LLC Compositions of poorly water soluble drugs with increased stability and methods for preparation thereof
US7919108B2 (en) * 2006-03-10 2011-04-05 Cook Incorporated Taxane coatings for implantable medical devices
US20080286325A1 (en) * 2006-01-05 2008-11-20 Med Institute, Inc. Cyclodextrin elution media for medical device coatings comprising a taxane therapeutic agent
US7875284B2 (en) * 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
GB0613925D0 (en) * 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions
WO2008120249A1 (en) 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
KR100785656B1 (ko) * 2007-05-14 2007-12-17 재단법인서울대학교산학협력재단 소염제로 사용되는 소디움글리코콜레이트 또는 그 유도체
US20140335166A1 (en) * 2013-05-08 2014-11-13 Michael W. Fountain Methods of Making and Using Nano Scale Particles
KR20160029866A (ko) * 2007-05-25 2016-03-15 더 유니버시티 오브 브리티쉬 콜롬비아 치료제의 경구 투여를 위한 제제 및 관련 방법
US8853284B2 (en) 2008-06-02 2014-10-07 Honeywell International Inc. Wax dispersion formulations, method of producing same, and uses
US20100305046A1 (en) 2009-06-02 2010-12-02 Abbott Medical Optics Inc. Stable cyclosporine containing ophthalmic emulsion for treating dry eyes
AU2014250656B2 (en) * 2009-06-02 2016-05-05 Johnson & Johnson Surgical Vision, Inc. Omega-3 oil containing ophthalmic emulsions
US9480645B2 (en) 2009-06-02 2016-11-01 Abbott Medical Optics Inc. Omega-3 oil containing ophthalmic emulsions
CN101904814A (zh) 2009-06-04 2010-12-08 上海恒瑞医药有限公司 制备载药乳剂的方法
EP2308468A1 (en) * 2009-10-08 2011-04-13 Novaliq GmbH Novel pharmaceutical composition comprising a macrolide immunosuppressant drug
WO2011050457A1 (en) 2009-10-26 2011-05-05 The University Of British Columbia Stabilized formulation for oral administration of therapeutic agents and related methods
TWI438009B (zh) * 2010-02-19 2014-05-21 Teikoku Pharma Usa Inc 紫杉烷前-乳劑調配物及其製造與使用之方法
CN101816423A (zh) * 2010-04-22 2010-09-01 王京南 紫苏籽油脂肪乳口服溶液、饮料及制造方法
NZ603828A (en) 2010-05-03 2015-09-25 Teikoku Pharma Usa Inc Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
AU2012204462A1 (en) 2011-01-05 2013-07-11 Hospira, Inc. Spray drying vancomycin
WO2012103421A1 (en) * 2011-01-27 2012-08-02 Novartis Ag Adjuvant nanoemulsions with crystallisation inhibitors
EP2768486B1 (en) * 2011-10-21 2018-10-03 First Tech International Limited Tocotrienol compositions
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN104043104B (zh) 2013-03-15 2018-07-10 浙江创新生物有限公司 含盐酸万古霉素的喷雾干粉及其工业化制备方法
WO2014208901A1 (ko) * 2013-06-24 2014-12-31 한국콜마주식회사 난용성 의약품의 수중유적형 에멀젼 조성물 및 이의 제조방법
CA2961746A1 (en) * 2014-09-17 2016-03-24 Vivacelle Bio, Inc. Stable micelle and/or liposome compositions and uses thereof
MY182652A (en) * 2014-11-25 2021-01-27 Kl Kepong Oleomas Sdn Bhd Formulation for effective tocotrienol delivery
CN107666902B (zh) * 2015-05-21 2021-09-21 德玛万科学有限责任公司 局部药物组合物
US11617724B2 (en) 2015-05-21 2023-04-04 Dermavant Sciences GmbH Topical pharmaceutical compositions
MA50637A (fr) * 2015-05-29 2020-08-05 Oculis Ehf Formation de nanoparticules de cyclosporine a/cyclodextrine
CN105769760B (zh) * 2016-04-14 2018-10-12 河北科星药业有限公司 布帕伐醌注射液及其制备方法
CA3027817C (en) * 2016-06-16 2023-12-19 The University Of Liverpool Chemical composition for the treatment and prophylaxis of systemic infections
LT3548091T (lt) 2016-11-29 2022-02-10 Oculis SA Kietųjų ciklodekstrino kompleksų paruošimas oftalminių aktyviųjų farmacinių ingredientų vartojimui
WO2019068161A1 (pt) * 2017-10-04 2019-04-11 Universidade De São Paulo - Usp Processo de obtenção de carreadores lipídicos nanoestruturados, carreadores lipídicos nanoestruturados obtidos e uso dos mesmos
US11497718B2 (en) 2018-11-13 2022-11-15 Dermavant Sciences GmbH Use of tapinarof for the treatment of atopic dermatitis
PL428779A1 (pl) * 2019-01-31 2020-08-10 Gdański Uniwersytet Medyczny Kompozycja farmaceutyczna w postaci ciekłej zawierająca jako substancję aktywną substancję leczniczą nietrwałą w środowisku wodnym
GB201904757D0 (en) * 2019-04-04 2019-05-22 Biorelevant Com Ltd Biorelevant composition
CN109989293B (zh) * 2019-04-26 2022-01-04 苏州赛维科环保技术服务有限公司 一种asa施胶剂乳液及其制备方法
CN114040766A (zh) 2019-07-01 2022-02-11 奥库里斯公司 用于稳定包含药物的水性组合物pH的方法
US12194047B2 (en) 2020-11-20 2025-01-14 Steps Biosciences, Inc. Stable antiemetic emulsions
AU2022345789A1 (en) * 2021-09-14 2024-03-28 Nulixir Inc. Alimentary-related particles, production methods, and production apparatus

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707470A (en) * 1985-05-17 1987-11-17 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
DE3623376A1 (de) * 1986-07-11 1988-01-21 Behringwerke Ag Pharmazeutische formulierung und verfahren zu deren herstellung
GB8714652D0 (en) * 1987-06-23 1987-07-29 Davis S S Drug emulsion
US5651991A (en) * 1987-10-28 1997-07-29 Nippon Shinyaku Co. Ltd. Drug carriers
US5534502A (en) * 1990-11-06 1996-07-09 Nippon Shinyaku Co. Ltd. Process for producing fat emulsion
US5529785A (en) * 1993-05-12 1996-06-25 Dietl; Hans Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing same
EP0570829B1 (de) * 1992-05-18 2001-04-25 CicloMulsion AG Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur intravenösen Applikation sowie Verfahren zu ihrer Herstellung
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US5622714A (en) * 1993-05-12 1997-04-22 Dietl; Hans Pharmaceutical preparation containing cyclosporine(s) for intravenous administration and process for its production
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
SE9303744D0 (sv) 1993-11-12 1993-11-12 Astra Ab Pharmaceutical emulsion
US5616330A (en) * 1994-07-19 1997-04-01 Hemagen/Pfc Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
DE4440337A1 (de) 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
US5660858A (en) * 1996-04-03 1997-08-26 Research Triangle Pharmaceuticals Cyclosporin emulsions
DE10036871A1 (de) * 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe

Also Published As

Publication number Publication date
CA2388550A1 (en) 2002-02-07
BR0107042A (pt) 2002-06-04
ATE401055T1 (de) 2008-08-15
MXPA02003114A (es) 2003-04-10
ES2307644T3 (es) 2008-12-01
WO2002009667A2 (de) 2002-02-07
WO2002009667A3 (de) 2002-11-07
AU8976801A (en) 2002-02-13
US20030059470A1 (en) 2003-03-27
DE50114130D1 (de) 2008-08-28
US20060188534A1 (en) 2006-08-24
DE10036871A1 (de) 2002-02-14
WO2002009667A9 (de) 2002-02-28
KR20020063869A (ko) 2002-08-05
JP2004505032A (ja) 2004-02-19
US7060285B2 (en) 2006-06-13
US7744909B2 (en) 2010-06-29
RU2002111336A (ru) 2003-11-20
CN1620283A (zh) 2005-05-25
EP1305006A2 (de) 2003-05-02
EP1305006B1 (de) 2008-07-16

Similar Documents

Publication Publication Date Title
PL365874A1 (pl) Dyspersje do wytwarzania słabo lub trudno rozpuszczalnych składników aktywnych
DE60131862D1 (de) Herstellung von vitaminemulsionen und konzentrate davon
EP2340710A3 (en) Stable emulsion formulation hindering interaction across the water-oil interface
IL114212A0 (en) Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
MX2007003727A (es) Composiciones de emulsion de bajo contenido de aceite para el suministro de taxoides y otros farmacos.
MA26288A1 (fr) Formulation microbicide comprenant des huiles essentielles ou leurs derives
WO2003015699A3 (en) Topical compositions and methods for treating pain
RS20090101A (en) Pickering emulsion formulations
UY27344A1 (es) Formulaciones autoemulsionantes
ATE479419T1 (de) Wässrige dispersion wasserunlöslicher organischer uv-filtersubstanzen
ZA200801227B (en) Intravenous propofol emulsion compositions having preservative efficacy
ATE365538T1 (de) O/w emulsion
DE59909759D1 (de) Emulgatorfreie und bornitrid enthaltende feindisperse systeme vom typ öl-in-wasser und wasser-in-öl
ATE410144T1 (de) Emulgierte parfümöle
MX380731B (es) Concentrados de emulsión pesticida que contienen aceites naturales o derivados del petróleo y métodos de uso.
EP1349545A4 (en) PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE WITH INCREASED BIOAVAILABILITY AND METHOD FOR THEIR USE
SE0000774D0 (sv) New formulation
KR960702733A (ko) 안정한 유중수형 유제(stable water-in-oil emulsions)
DE602006001226D1 (de) Schäumende O/W-Emulsion und ihre Verwendung in der Kosmetik
MX2022014226A (es) Composiciones para la administracion de agentes bioactivos en foliculos pilosos.
EA200200217A1 (ru) Парентеральная цисплатиновая эмульсия
ATE329570T1 (de) Emulsion enthaltend siliconöl- und co- lösungsmittelsystem enhaltend fettlösliche kosmetische wirkstoffe und daraus hergestelleten kosmetischen zubereitungen
FR2909556B1 (fr) Creme photoprotectrice a base d'acide gras
MX2021013144A (es) Biofungicida botanico derivado de pimenta dioica, para el control de la moniliasis en el cultivo del cacao.
ATE458406T1 (de) Geniessbarer emulsionsaufstrich

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)